Observational Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Oct 26, 2022; 10(30): 10921-10930
Published online Oct 26, 2022. doi: 10.12998/wjcc.v10.i30.10921
Table 2 Medical treatment in patients with ulcerative colitis
Medical therapy
Current users, n (%)
Former users, n (%)
Never used, n (%)
Mesalazine, n = 425368 (86.6)46 (10.8)11 (2.6)
Corticosteroids41 (9.1)228 (51.7)173 (39.2)
Thiopurines40 (9)69 (15.6)333 (75.4)
Methotrexate5 (1.1)4 (1)432 (97.9)
Infliximab55 (12.4)22 (5.0)365 (82.6)
Adalimumab12 (2.7)6 (1.4)424 (95.9)
Golimumab5 (1.1)11 (2.5)426 (96.4)
Vedolizumab11 (2.5)1 (0.2)430 (97.3)